R-GVD Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C140733
A regimen consisting of rituximab, gemcitabine, vinorelbine and pegylated liposomal doxorubicin that can be used in the treatment of Hodgkin lymphoma (HL) and diffuse large B-cell lymphoma (DLBCL). [ ]
Term info
Label
R-GVD Regimen
Synonyms
- Gemcitabine-Vinorelbine-Pegylated Liposomal Doxorubicin-Rituximab
- Gemcitabine/Vinorelbine/Doxil/Rituximab
- Gemcitabine/Vinorelbine/Pegylated Liposomal Doxorubicin/Rituximab
- R-GVD
- R-GVD Regimen
- Rituximab/Gemcitabine/Vinorelbine/Pegylated Liposomal Doxorubicin
Subsets
NCIT_C160952, NCIT_C160950
NCI META CUI
CL538819
Preferred Name
R-GVD Regimen
Semantic Type
Therapeutic or Preventive Procedure
code
C140733
Term relations
Subclass of:
- Regimen Used to Treat Hodgkin Lymphoma
- Chemotherapy_Regimen_Has_Component some Gemcitabine Hydrochloride
- Chemotherapy_Regimen_Has_Component some Vinorelbine Tartrate
- Chemotherapy_Regimen_Has_Component some Pegylated Liposomal Doxorubicin Hydrochloride
- Chemotherapy_Regimen_Has_Component some Rituximab